Sofinnova Investments' Jakob Dupont on the private markets in biotech
Jakob Dupont says he is focused on clinical stage companies or ones that are months within IND. He thinks the IPO market will be available for advanced companies in 2024.
Also look for unique social pages for BiotechTV U.
#1. Pfizer’s CEO on Q2 earnings.
​
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
​
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
​
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square